Want to see KR:096760 full AI Analyst Report?
096760 Stock Chart & Stats
₩3965.00
-₩35.00(-0.88%)
―
--
Day’s Range― - ―
52-Week Range₩3,195.00 - ₩4,720.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)57.05K
Market Cap
₩274.34B
Enterprise Value₩863.67B
Total Cash (Recent Filing)₩103.36B
Total Debt (Recent Filing)₩357.03B
Price to Earnings (P/E)3.3
Beta0.17
Next Earnings
Nov 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield5.42%
Share Statistics
EPS (TTM)1218.54
Shares Outstanding73,924,940
10 Day Avg. Volume48,304
30 Day Avg. Volume57,046
Financial Highlights & Ratios
PEG Ratio-1.12
Price to Book (P/B)0.94
Price to Sales (P/S)0.26
P/FCF Ratio1.86
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improved ProfitabilityThe shift to consistently positive earnings and an improved net margin indicates stronger profitability than in earlier years. Stable gross margins around 49–50% provide a durable base for earnings resilience, helping the group retain more revenue as profit across its healthcare-related businesses.
Strong Cash GenerationStrong conversion of accounting earnings into free cash flow improves the company’s ability to fund operations, support shareholder returns, and reduce financial obligations internally. The 34% FCF increase suggests cash generation is strengthening, although sustained generation remains important for balance-sheet improvement.
Stable Family GovernanceThe controlling family’s majority ownership provides continuity in shareholder influence and group-level governance. The reported incremental accumulation also points to long-term stewardship and stable control, which can support consistent strategic oversight across JW Holdings’ affiliated healthcare businesses.
Bears Say
Above-Average LeverageDebt remains high relative to equity, leaving the company more exposed to financing pressure than a lightly leveraged balance sheet would be. Although equity rebuilding has improved the position, leverage can constrain strategic flexibility and partially amplify reported returns such as the approximately 31% TTM ROE.
Limited Debt CoverageCash generation is strong, but current operating cash flow covers only a relatively small portion of total debt. This means meaningful deleveraging would likely require several years of sustained cash generation, limiting the funds available for reinvestment, acquisitions, or other capital-allocation priorities.
Uneven Revenue GrowthRecent revenue performance has not yet established a consistently expanding top line. A flat latest annual period and a prior decline suggest that improved margins and cash flow are not being supported by uniformly strong demand growth, which may limit the durability of future earnings expansion.
JW Holdings Corporation News
096760 FAQ
What was JW Holdings Corporation’s price range in the past 12 months?
JW Holdings Corporation lowest stock price was ₩3195.00 and its highest was ₩4720.00 in the past 12 months.
What is JW Holdings Corporation’s market cap?
JW Holdings Corporation’s market cap is ₩274.34B.
When is JW Holdings Corporation’s upcoming earnings report date?
JW Holdings Corporation’s upcoming earnings report date is Nov 18, 2026 which is in 18 days.
How were JW Holdings Corporation’s earnings last quarter?
JW Holdings Corporation released its earnings results on Aug 14, 2026. The company reported ₩281.028 earnings per share for the quarter.
Is JW Holdings Corporation overvalued?
According to Wall Street analysts JW Holdings Corporation’s price is currently Undervalued.
Does JW Holdings Corporation pay dividends?
JW Holdings Corporation pays a Notavailable dividend of ₩215 which represents an annual dividend yield of 5.42%. See more information on JW Holdings Corporation dividends here
What is JW Holdings Corporation’s EPS estimate?
JW Holdings Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does JW Holdings Corporation have?
JW Holdings Corporation has 73,924,940 shares outstanding.
What happened to JW Holdings Corporation’s price movement after its last earnings report?
JW Holdings Corporation reported an EPS of ₩281.028 in its last earnings report. Following the earnings report the stock price went up 2.605%.
Which hedge fund is a major shareholder of JW Holdings Corporation?
Currently, no hedge funds are holding shares in KR:096760
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
JW Holdings Corporation
JW Holdings Corporation, alongside its numerous subsidiaries, is a key player in the manufacturing and commercialization of pharmaceuticals and medical devices. Its operations span South Korea and global markets. The company's diverse offerings include ethical medications, non-prescription consumer health goods, and specialized equipment for IV solutions. Established in 1945, JW Holdings maintains its headquarters in Seoul, South Korea.
Technical Analysis
Dong-A Socio Holdings Co., Ltd.
―
JW Pharmaceutical Corporation
―
Bukwang Pharmaceutical Co., Ltd.
―
Daewoong Pharmaceutical Co., Ltd.
―
Ildong Pharmaceutical Co., Ltd.
―
